Searched for: in-biosketch:true
person:stojaj01
Role of Cardiac Imaging in Myocardial Infarction With Non-Obstructive Coronary Arteries
Alonso, Ana Isabel Barrio; Cabrero, Jordi Broncano; Stojanovska, Jadranka; Valle, José Miguel Vegas; Val, Javier Royuela Del; Alcalá, Antonio Luna
Myocardial infarction with non-obstructive coronary arteries (MINOCA) represents a dynamic and evolving clinical entity, defined by two key components: the presence of acute myocardial infarction and the absence of obstructive coronary artery disease. Contrary to earlier perceptions of MINOCA as a benign condition, accumulating evidence underscores its association with significant morbidity and major adverse cardiac events. Recent clinical guidelines advocate for a structured, three-step "traffic light" approach to differentiate non-cardiac causes of elevated cardiac troponins from ischemic and non-ischemic cardiac entities. Cardiac magnetic resonance (CMR), with its unparalleled tissue characterization capabilities, plays a pivotal role in identifying ischemic patterns, including regional wall motion abnormalities, myocardial edema, and late gadolinium enhancement, facilitating differentiation from non-ischemic causes such as Takotsubo cardiomyopathy and acute myocarditis. The combination of CMR with intravascular imaging has been shown to be the most effective approach for identifying the underlying ischemic mechanisms of MINOCA. Furthermore, CMR provides critical prognostic insights, enabling the identification of patients at elevated risk for adverse cardiovascular outcomes. The integration of CMR into the diagnostic and management pathways of MINOCA holds substantial promise for the improvement of patient outcomes and advancing our understanding of this multifaceted clinical entity.
PMID: 40444434
ISSN: 1540-8175
CID: 5854462
Highlights of the Cardiovascular Magnetic Resonance 2024 Conference: the first joint European Association of Cardiovascular Imaging, European Society of Cardiovascular Radiology, and Society for Cardiovascular Magnetic Resonance conference
Stojanovska, Jadranka; Nijveldt, Robin; Ordovas, Karen; Vliegenthart, Rozemarijn; Seiberlich, Nicole; Prieto, Claudia; Ojha, Vineeta; Hanneman, Kate; Lawton, Benny; Hughes, Marina; Ferreira, Vanessa; Grizzard, John; Natale, Luigi; Kim, Daniel; Bucciarelli-Ducci, Chiara; Petersen, Steffen; Treibel, Thomas A
Cardiovascular Magnetic Resonance 2024 Conference (CMR2024) convened in London, UK, from 24 to 26 January 2024 and brought together 2705 learners and renowned cardiac imaging professionals to discuss and learn about the latest advancements. Organized by the Society for Cardiovascular Magnetic Resonance (SCMR) and the European Association of Cardiovascular Imaging (EACVI), in collaboration with the European Society of Cardiovascular Radiology (ESCR), CMR2024 was the largest international cardiac magnetic resonance conference to date. This conference underscored the collaboration between cardiologists, radiologists, scientists, and technologists by bringing together three major societies-SCMR, EACVI, and ESCR. Innovative session formats like 'Shark Tank' and 'Workflow, Innovations & Patients' facilitated expert opinion and practical experiences sharing in a 'TED-talk style'. With over 1168 abstract submissions and 75% acceptance rate, the programme featured multiple Early Career Award sessions, oral scientific sessions, oral case sessions, and rapid-fire sessions, all categorized by topic. Highlights included patient- and physician-centred imaging sessions, sharing referring physicians' and patients' insights of incremental value of cardiovascular magnetic resonance (CMR) in patient's management. The programme offered invited lectures in eight parallel tracks with three plenary and two keynote speakers. In addition, the interactive workshops and panel discussions provided a platform for knowledge exchange, support, and collaboration. A great emphasis was placed on collaboration between radiologists, cardiologists, scientists, and technologists, showcasing an ideal cardiac imaging marriage as a model for enhanced patient care around the globe. The event also featured exhibitions of the latest CMR technology and software, offering attendees a glimpse into the future cardiac imaging. CMR2024 emerged as a remarkable scientific, educational, and networking event, inspiring attendees to learn and collaborate within the global CMR community.
PMID: 39935424
ISSN: 2047-2412
CID: 5793462
Highlights of the Cardiovascular Magnetic Resonance 2024 Conference: the first joint European Association of Cardiovascular Imaging, European Society of Cardiovascular Radiology, and Society for Cardiovascular Magnetic Resonance conference
Stojanovska, Jadranka; Nijveldt, Robin; Ordovas, Karen; Vliegenthart, Rozemarijn; Seiberlich, Nicole; Prieto, Claudia; Ojha, Vineeta; Hanneman, Kate; Lawton, Benny; Hughes, Marina; Ferreira, Vanessa; Grizzard, John; Natale, Luigi; Kim, Daniel; Bucciarelli-Ducci, Chiara; Petersen, Steffen; Treibel, Thomas A
Cardiovascular Magnetic Resonance 2024 Conference (CMR2024) convened in London, UK, from 24 to 26 January 2024 and brought together 2705 learners and renowned cardiac imaging professionals to discuss and learn about the latest advancements. Organized by the Society for Cardiovascular Magnetic Resonance (SCMR) and the European Association of Cardiovascular Imaging (EACVI), in collaboration with the European Society of Cardiovascular Radiology (ESCR), CMR2024 was the largest international cardiac magnetic resonance conference to date. This conference underscored the collaboration between cardiologists, radiologists, scientists, and technologists by bringing together three major societies-SCMR, EACVI, and ESCR. Innovative session formats like 'Shark Tank' and 'Workflow, Innovations & Patients' facilitated expert opinion and practical experiences sharing in a 'TED-talk style'. With over 1168 abstract submissions and 75% acceptance rate, the programme featured multiple Early Career Award sessions, oral scientific sessions, oral case sessions, and rapid-fire sessions, all categorized by topic. Highlights included patient- and physician-centred imaging sessions, sharing referring physicians' and patients' insights of incremental value of cardiovascular magnetic resonance (CMR) in patient's management. The programme offered invited lectures in eight parallel tracks with three plenary and two keynote speakers. In addition, the interactive workshops and panel discussions provided a platform for knowledge exchange, support, and collaboration. A great emphasis was placed on collaboration between radiologists, cardiologists, scientists, and technologists, showcasing an ideal cardiac imaging marriage as a model for enhanced patient care around the globe. The event also featured exhibitions of the latest CMR technology and software, offering attendees a glimpse into the future cardiac imaging. CMR2024 emerged as a remarkable scientific, educational, and networking event, in-spiring attendees to learn and collaborate within the global CMR community.
PMID: 39948014
ISSN: 1532-429x
CID: 5793862
Advanced Computed Tomography and Magnetic Resonance Imaging in Ischemic and Nonischemic Cardiomyopathies
Tamizuddin, Farah; Stojanovska, Jadranka; Toussie, Danielle; Shmukler, Anna; Axel, Leon; Srinivasan, Ranjini; Fujikura, Kana; Broncano, Jordi; Frank, Luba; Villasana-Gomez, Geraldine
Cardiomyopathies represent a diverse group of heart diseases that can be broadly classified into ischemic and nonischemic etiologies, each requiring distinct diagnostic approaches. Noninvasive imaging modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), play a pivotal role in the diagnosis, risk stratification, and prognosis of these conditions. This paper reviews the characteristic CT and MRI findings associated with ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM), focusing on their ability to provide detailed anatomical, functional, and tissue characterization. In ICM, CT and MRI reveal myocardial scarring, infarct size, and coronary artery disease, while MRI further distinguishes tissue viability through late gadolinium enhancement (LGE). Conversely, nonischemic cardiomyopathies demonstrate a wide array of findings, with MRI's LGE pattern analysis being particularly critical for identifying specific subtypes, such as restrictive, hypertrophic, or dilated cardiomyopathies. By comparing the strengths and limitations of these modalities, this paper highlights their complementary roles in improving diagnostic accuracy, risk stratification, prognosis, and therapeutic decision making in both ischemic and nonischemic cardiomyopathies.
PMID: 39950567
ISSN: 1540-8175
CID: 5793952
Cardio-Oncology Program Building: A Practical Guide
Bloom, Michelle Weisfelner; Ferrari, Alana M; Stojanovska, Jadranka; Harnden, Kathleen Kiernan; Beckford, Yaisa; Skurka, Kerry; Barac, Ana
The organization of a cardio-oncology clinic and overall program is designed to provide comprehensive cardiovascular care to patients who are at risk of or have developed cardiovascular sequelae during or following cancer treatments. In this article, we summarize the core components of a contemporary cardio-oncology program, including its core members (cardiologists, oncologists, clinical pharmacists, advanced practice providers, nurses, and coordinators), key services (risk assessment, treatment planning, cardiac imaging, intervention, and management), and practical integration within the health care system.
PMID: 39551558
ISSN: 1558-2264
CID: 5757962
Incidental Apical Pleuroparenchymal Scarring on Computed Tomography: Diagnostic Yield, Progression, Morphologic Features and Clinical Significance
Toussie, Danielle; Finkelstein, Mark; Mendoza, Dexter; Concepcion, Jose; Stojanovska, Jadranka; Azour, Lea; Ko, Jane P; Moore, William H; Singh, Ayushi; Sasson, Arielle; Bhattacharji, Priya; Eber, Corey
PURPOSE/OBJECTIVE:Apical pleuroparenchymal scarring (APPS) is commonly seen on chest computed tomography (CT), though the imaging and clinical features, to the best of our knowledge, have never been studied. The purpose was to understand APPS's typical morphologic appearance and associated clinical features. PATIENTS AND METHODS/METHODS:A random generator selected 1000 adult patients from all 21516 chest CTs performed at urban outpatient centers from January 1, 2016 to December 31, 2016. Patients with obscuring apical diseases were excluded to eliminate confounding factors. After exclusions, 780 patients (median age: 64 y; interquartile range: 56 to 72 y; 55% males) were included for analysis. Two radiologists evaluated the lung apices of each CT for the extent of abnormality in the axial plane (mild: <5 mm, moderate: 5 to 10 mm, severe: >10 mm), craniocaudal plane (extension halfway to the aortic arch, more than halfway, vs below the arch), the predominant pattern (nodular vs reticular and symmetry), and progression. Cohen kappa coefficient was used to assess radiologists' agreement in scoring. Ordinal logistic regression was used to determine associations of clinical and imaging variables with APPS. RESULTS:APPS was present on 65% (507/780) of chest CTs (54% mild axial; 80% mild craniocaudal). The predominant pattern was nodular and symmetric. Greater age, female sex, lower body mass index, greater height, and white race were associated with more extensive APPS. APPS was not found to be associated with lung cancer in this cohort. CONCLUSION/CONCLUSIONS:Classifying APPS by the extent of disease in the axial or craniocaudal planes, in addition to the predominant pattern, enabled statistically significant associations to be determined, which may aid in understanding the pathophysiology of apical scarring and potential associated risks.
PMID: 38798201
ISSN: 1536-0237
CID: 5663232
Editorial for "Liver T1 Mapping Derived From Cardiac Magnetic Resonance Imaging: A Potential Prognostic Marker in Idiopathic Dilated Cardiomyopathy" [Comment]
Stojanovska, Jadranka; Feng, Li; Gilani, Nima
PMID: 38180166
ISSN: 1522-2586
CID: 5732162
The Society for Cardiovascular Magnetic Resonance Registry at 150,000
Tong, Matthew S; Slivnick, Jeremy A; Sharif, Behzad; Kim, Han W; Young, Alistair A; Sierra-Galan, Lilia M; Mukai, Kanae; Farzaneh-Far, Afshin; Al-Kindi, Sadeer; Chan, Angel T; Dibu, George; Elliott, Michael D; Ferreira, Vanessa M; Grizzard, John; Kelle, Sebastian; Lee, Simon; Malahfji, Maan; Petersen, Steffen E; Polsani, Venkateshwar; Toro-Salazar, Olga H; Shaikh, Kamran A; Shenoy, Chetan; Srichai, Monvadi B; Stojanovska, Jadranka; Tao, Qian; Wei, Janet; Weinsaft, Jonathan W; Wince, W Benjamin; Chudgar, Priya D; Judd, Matthew; Judd, Robert M; Shah, Dipan J; Simonetti, Orlando P
BACKGROUND:Cardiovascular magnetic resonance (CMR) is increasingly utilized to evaluate expanding cardiovascular conditions. The Society for Cardiovascular Magnetic Resonance (SCMR) Registry is a central repository for real-world clinical data to support cardiovascular research, including those relating to outcomes, quality improvement, and machine learning. The SCMR Registry is built on a regulatory-compliant, cloud-based infrastructure that houses searchable content and Digital Imaging and Communications in Medicine images. The goal of this study is to summarize the status of the SCMR Registry at 150,000 exams. METHODS:The processes for data security, data submission, and research access are outlined. We interrogated the Registry and presented a summary of its contents. RESULTS:Data were compiled from 154,458 CMR scans across 20 United States sites, containing 299,622,066 total images (∼100 terabytes of storage). Across reported values, the human subjects had an average age of 58 years (range 1 month to >90 years old), were 44% (63,070/145,275) female, 72% (69,766/98,008) Caucasian, and had a mortality rate of 8% (9,962/132,979). The most common indication was cardiomyopathy (35,369/131,581, 27%), and most frequently used current procedural terminology code was 75561 (57,195/162,901, 35%). Macrocyclic gadolinium-based contrast agents represented 89% (83,089/93,884) of contrast utilization after 2015. Short-axis cines were performed in 99% (76,859/77,871) of tagged scans, short-axis late gadolinium enhancement (LGE) in 66% (51,591/77,871), and stress perfusion sequences in 30% (23,241/77,871). Mortality data demonstrated increased mortality in patients with left ventricular ejection fraction <35%, the presence of wall motion abnormalities, stress perfusion defects, and infarct LGE, compared to those without these markers. There were 456,678 patient-years of all-cause mortality follow-up, with a median follow-up time of 3.6 years. CONCLUSION/CONCLUSIONS:The vision of the SCMR Registry is to promote evidence-based utilization of CMR through a collaborative effort by providing a web mechanism for centers to securely upload de-identified data and images for research, education, and quality control. The Registry quantifies changing practice over time and supports large-scale real-world multicenter observational studies of prognostic utility.
PMCID:11314894
PMID: 38971501
ISSN: 1532-429x
CID: 5698512
Invited Commentary: Mitral Annular Disease: An Underrecognized and Forgotten Entity
Stojanovska, Jadranka; Fujikura, Kana
PMID: 38870046
ISSN: 1527-1323
CID: 5669322
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device
Kim, Daniel; Collins, Jeremy D; White, James A; Hanneman, Kate; Lee, Daniel C; Patel, Amit R; Hu, Peng; Litt, Harold; Weinsaft, Jonathan W; Davids, Rachel; Mukai, Kanae; Ng, Ming-Yen; Luetkens, Julian A; Roguin, Ariel; Rochitte, Carlos E; Woodard, Pamela K; Manisty, Charlotte; Zareba, Karolina M; Mont, Lluis; Bogun, Frank; Ennis, Daniel B; Nazarian, Saman; Webster, Gregory; Stojanovska, Jadranka
Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.
PMID: 38219955
ISSN: 1532-429x
CID: 5668442